Current partner codePEPTIDESDE
PeptideStat
Menu

Vendors

Compare pricesVendor directoryVendor reviewsDiscount codesLab tests & COAs

Research

ResearchDatabaseClinical trials

Tools

All calculatorsReconstitutionAccumulationUnit converterPeptide chemistry

Development-stage index

Phase 1Peptide Trials.

Explore every Phase 1 peptide study in the local registry snapshot. Compare recruitment, sponsors, therapeutic areas, enrollment, results, publications and study geography.

Studies
384
Recruiting
48
Completed
254
Results posted
47
Countries
43
Avg enrollment
52

Velocity

Phase 1 trials by start year

Study start year · indexed snapshot

43322211019971997: 1 trials1998: 0 trials1999: 0 trials2000: 0 trials2001: 4 trials2002: 2 trials20032003: 1 trials2004: 2 trials2005: 1 trials2006: 6 trials2007: 6 trials2008: 10 trials20092009: 7 trials2010: 16 trials2011: 15 trials2012: 18 trials2013: 7 trials2014: 8 trials20152015: 12 trials2016: 11 trials2017: 16 trials2018: 16 trials2019: 16 trials2020: 17 trials20212021: 20 trials2022: 27 trials2023: 31 trials2024: 43 trials2025: 37 trials2026: 33 trials20272027: 1 trials

Development

Trials by phase

Early Phase 10
Phase 1384
Phase 277
Phase 30
Phase 40

Industry

Leading sponsors

Eli Lilly35
Novo Nordisk35
Boehringer Ingelheim19
Amgen14
Stealth BioTherapeutics Inc.12
Novartis11
Zealand Pharma9
AstraZeneca8

Therapeutic areas

Condition groups

Weight loss95
Type 2 diabetes22
Inflammation6
Brain health5
Longevity4
Pain3

Compound leaders

Most represented peptides.

01Survodutide1902Cagrilintide1703Pasireotide1704Retatrutide1505Maridebart cafraglutide1406Octreotide1407Cotadutide1308Elamipretide1309Mazdutide1210Degarelix1111Exenatide1112Pemvidutide11

Study explorer

Search this collection.

384 matching studies